Merve Çakır

7.8k total citations
9 papers, 340 citations indexed

About

Merve Çakır is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Merve Çakır has authored 9 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Computational Theory and Mathematics. Recurrent topics in Merve Çakır's work include CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and Computational Drug Discovery Methods (2 papers). Merve Çakır is often cited by papers focused on CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and Computational Drug Discovery Methods (2 papers). Merve Çakır collaborates with scholars based in United States and Türkiye. Merve Çakır's co-authors include Kris C. Wood, Grace R. Anderson, Suzanne E. Wardell, Donald P. McDonnell, Ryan S. Soderquist, Peter Winter, Lorin Crawford, Lucie Ahn, Christina Chao and Nevan J. Krogan and has published in prestigious journals such as Nature Communications, Scientific Reports and Science Advances.

In The Last Decade

Merve Çakır

9 papers receiving 337 citations

Peers

Merve Çakır

MB

ONCOL

CR

EPIDE

ID

Lei Lou China

Jasper E. Neggers United States

Shaolin Ma China

Kenly Wuputra Taiwan

Angelo Limeta Sweden

Brittney S. Harrington United States

Anatoly Prokvolit United States

Rongyu Zhang China

Diane Yang United States

Srilakshmi Srinivasan Australia

Lei Lou China

Merve Çakır

274 ×1.1

MB

80 ×1.0

ONCOL

97 ×1.5

CR

29 ×0.9

EPIDE

22 ×0.6

ID

Citations per year, relative to Merve Çakır Merve Çakır (= 1×) peers Lei Lou

Countries citing papers authored by Merve Çakır

Since Specialization

Citations

This map shows the geographic impact of Merve Çakır's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merve Çakır with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merve Çakır more than expected).

Fields of papers citing papers by Merve Çakır

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merve Çakır. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merve Çakır. The network helps show where Merve Çakır may publish in the future.

Co-authorship network of co-authors of Merve Çakır

This figure shows the co-authorship network connecting the top 25 collaborators of Merve Çakır. A scholar is included among the top collaborators of Merve Çakır based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merve Çakır. Merve Çakır is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Martz, Colin A., Andrew M. Waters, Alejandro Barrera, et al.. (2024). Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers. npj Precision Oncology. 8(1). 124–124. 3 indexed citations

2.

Çakır, Merve, Kirsten Obernier, Antoine Forget, & Nevan J. Krogan. (2021). Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches. mSystems. 6(5). e0038821–e0038821. 18 indexed citations

3.

Tutuncuoglu, Beril, Merve Çakır, Jyoti Batra, et al.. (2020). The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2. Cancer Discovery. 10(7). 916–921. 42 indexed citations

4.

Çakır, Merve, Sayan Mukherjee, & Kris C. Wood. (2019). Label propagation defines signaling networks associated with recurrently mutated cancer genes. Scientific Reports. 9(1). 9401–9401. 1 indexed citations

5.

Manzari, Mandana T., Grace R. Anderson, Kevin Lin, et al.. (2019). Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models. Science Advances. 5(9). eaaw9162–eaaw9162. 13 indexed citations

6.

Soderquist, Ryan S., Lorin Crawford, Esther Liu, et al.. (2018). Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity. Nature Communications. 9(1). 3513–3513. 90 indexed citations

7.

Anderson, Grace R., Suzanne E. Wardell, Merve Çakır, et al.. (2018). Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors. Nature Communications. 9(1). 1677–1677. 111 indexed citations

8.

Anderson, Grace R., Suzanne E. Wardell, Merve Çakır, et al.. (2016). PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation. Science Translational Medicine. 8(369). 369ra175–369ra175. 42 indexed citations

9.

Babur, Özgün, Uğur Doğrusöz, Merve Çakır, et al.. (2014). Integrating biological pathways and genomic profiles with ChiBE 2. BMC Genomics. 15(1). 642–642. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact